TNXP

Tonix Pharmaceut

• Reuters·4d ago

  Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash

• TipRanks·5d ago

  Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Nuvalent (NUVL) and Tonix Pharma (TNXP)

• TipRanks·04/04 13:00

  Insiders Shake Up Vale, Gevo, Macy’s, Tonix, Southern

• TipRanks·04/02 02:03

  Tonix Pharma CEO Makes Bold Insider Move Amid Market Uncertainty

• Reuters·04/01 13:31

  Tonix CEO Seth Lederman buys TNXP shares worth $0.1 million

• Reuters·04/01 13:29

  Tonix publishes investor presentation highlighting TONMYA fibromyalgia launch and early sales traction

• Reuters·03/31 22:25

  Tonix publishes presentation on long-acting monoclonal antibody to prevent Lyme disease

• Reuters·03/31 21:48

  Tonix publishes investor presentation highlighting TONMYA fibromyalgia drug launch progress

• Reuters·03/31 21:18

  Tonix plans adaptive Phase 2 field trial of TNX-4800 for Lyme prevention in 2027

• Reuters·03/31 21:06

  Tonix publishes TNX-4800 long-acting monoclonal antibody presentation for Lyme disease prevention

• TipRanks·03/31 14:45

  Tonix Pharma Advances TNX-4800 Lyme Disease Prevention Program

• TipRanks·03/31 11:25

  Tonix Pharmaceuticals presents TNX-4800 data, to initiate adaptive field study

• Benzinga·03/31 11:10

  Tonix Pharmaceuticals Says Phase 1 Data of TNX-4800 (mAb 2217LS) For Preventing Lyme Disease Demonstrated Safety, Tolerability, And Pharmacokinetics Supportive Of Approximately Four Months Protection

• Reuters·03/31 11:00

  TONIX PHARMACEUTICALS ANNOUNCES PRESENTATION OF PHASE 1 DATA AND OUTLINES PLANNED ADAPTIVE PHASE 2 FIELD STUDY OF TNX-4800 FOR THE PREVENTION OF LYME DISEASE, AT THE WORLD VACCINE CONGRESS WASHINGTON 2026

• Benzinga·03/30 15:43

  Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?